Skip to content
Politics
Prognosis

Pandemic Readiness Lobby Draws Biotech, Government Members

  • Former US health officials form biosecurity-focused coalition
  • Medical Countermeasures Coalition draws in Genentech, Flagship
A laboratory worker inserts test tubes into a patient sample analysis machine at UZ Leuven university hospital in Leuven, Belgium.

A laboratory worker inserts test tubes into a patient sample analysis machine at UZ Leuven university hospital in Leuven, Belgium.

Photographer: Geert Vanden Wijngaert/Bloomberg
Updated on

Drug and biotechnology firms, academics, investors and former government officials are launching a new lobbying group that hopes to improve long-term support for technology and products to combat future pandemics and other biological threats.

Initial members of the group include Roche Holding AG’s Genentech unit, Flagship Pioneering Inc., Ginkgo Bioworks Holdings Inc., Siga Technologies Inc., Coherus Biosciences Inc., ImmunityBio Inc., IGM Biosciences Inc., Texas A&M University and the University of Nebraska Medical Center.